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Aptamer-based assays are a powerful platform for sensing a wide variety of 
biochemical targets, including drugs, disease biomarker, and biomolecules. 
However, aptamer assays often lack rapid identification and high-throughput 
screening. Performing an aptamer-based assay on a microfluidic device is a 
promising solution to increase throughput, portability, and sensitivity. In this paper, 
we present a microfluidic device capable of running aptamer-based assays. Our 
device utilizes normally-closed valves and a central micropump to move fluids 
throughout the chip. One chip could theoretically be scaled up to run multiple 
assays, and multiple of these microfluidic devices could be run in parallel to 
increase throughput. Our experiments characterized the actuation pressure needed 
to normally-closed valves with different size parameters, showed and characterized 
flow using both oil and water solutions, and demonstrated modular movement on a 
chip with six micropumps. Lastly, we designed a cartridge topper system to 
eliminate the need for pins leading to a pneumatic controller so chips could easily 
be switched out. By demonstrating flow and mixing, our chip is fully capable of 
running an aptamer-based assay.  
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In recent years, aptamer-based assays have been developed for the screening of various 
diseases.1 Aptamers, compromised of single strands of DNA or RNA, exhibit high affinity and 
selectivity to a variety of biomolecular targets. Aptamers offer an alternative to antibodies in 
diagnostic assays and have several advantages, including lower cost, ease of chemical 
modification, and a smaller size. Although aptamer research shows a lot of promise, current 
aptamer assays lack the rapid identification and ease of high throughput screening.2 The ability 
to run aptamer assays on microfluidic chips provides a robust and efficient solution to this. 
Microfluidic chips manipulate fluids on the micro- to nano-scale.3 The chips can be automated 
and scaled-up. The objective of the project is to design a high-throughput and portable 
microfluidic device to run antibody-aptamer hybrid ELISA assay to test the binding of aptamers 
to a variety of peptide constructs. 
1.2 Statement of Project Objectives 
Our project has three main objectives: 
1. Create a microfluidic system utilizing normally-closed valves, allowing increased 
portability, and micropumps, allowing fluids to be moved throughout the chip and mixed. 
2. Characterize the actuation pressure of different normally-closed valves and determine the 
pumping rates of different sized micropumps. 
3. Develop a protocol to run an aptamer-based assay on the microfluidic chip. 
 
1.3 Review of Field and Related Literature 
1.3.1 Aptamer Overview 
Aptamers are short, single strands of oligonucleotides, either DNA or RNA, that can have high 
affinity and specificity for a certain target. Affinity refers to how strong aptamers will bind to 
their targets, and specificity refers to the ability of the aptamers to bind to the target over other 
similar biomolecules. Due to the inherent base-pairing properties of DNA, aptamers will form 
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unique three-dimensional structures (Figure 1-1).4 These structures give aptamers their ability to 
bind to a wide range of biomolecular targets. 
 
 
Figure 1-1: Aptamer sequence dictates 3D structure formation which dictates target binding to a variety of 
biomarkers. Source: Sun, et al.4 
 
Aptamers are commonly evolved through the systematic evolution of ligands by exponential 
enrichment (SELEX) process (Figure 1-2).5 The SELEX process starts with a large pool of 
random DNA sequences, ranging from 1010-1014 sequences. The sequences are incubated with 
the biomolecular target of interest, where strands with higher affinity for the target will bind to 
the target. The bound oligonucleotides are separated from the unbound oligonucleotides using 
various techniques including filter binding assays and capillary electrophoresis.6These bound 
oligonucleotides are then separated from the biomolecular target and are amplified using 
polymerase chain reaction (PCR), creating a narrower, more selective DNA pool. After several 
rounds of incubating the isolated DNA pool with the target of interest, the resulting aptamers will 
have a higher affinity for the target. To obtain high selectivity, the DNA pool can be incubated 
with a biomolecule similar to the target of interest. In these counter-selection rounds, the 




Figure 1-2: Capillary electrophoresis SELEX process for isolating aptamers specific for a biomarker. After 
isolation, these aptamers can be translated into aptamer-based assays.  
 
Traditionally, antibodies have been used in assays due to their high affinity and specificity for a 
wide range of biomolecular targets, including cocaine,7 dopamine,8 Zika virus,9 and HIV reverse 
transcriptase.10 Aptamers offer several advantages over antibodies, including 1) smaller size and 
the ability to bind to a wider variety of targets, 2) a structure that is more readily chemically 
modifiable and compatible with a variety of functional groups, 3) cheaper and easier production 
due to the ease of DNA synthesis, and 4) stability at higher temperatures.1 Because functional 
groups can be inserted on aptamers, aptamers can be readily conjugated to a variety of surfaces, 
which is key in aptamer-based assays. 
 
1.3.2 Aptamer-Based Assay 
Assays are used in a variety of fields to assess the presence of a certain molecule, biomolecule, 
organism, or biomarkers within a specific sample. Aptamer-based assays include a variety of 
techniques. Aptamer assays are composed of a capture agent, often fixed to a surface, that has 
high affinity and selectivity for the target that binds to the target, and a reporter agent, often in 
free solution, which gives a measurable signal, such as fluorescence. Aptamers can function as 
the capture agent, the reporter agent, or both. They can be fixed to plates as shown by Lee et al.,9 
attached to microspheres as shown by Lin et al.,11 or attached to magnetic beads as shown by Li 
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et al.12 Some aptamer-based assays will also include antibodies and function as a hybrid assay. 
All of these assays analyze a liquid sample, often human serum, to detect a biomolecular target. 
  
Most high-throughput biomolecule assays are based on a sandwich format, such as the common 
enzyme-linked immunosorbent assays (ELISA). One approach to aptamer-based assays utilizes a 
sandwich assay.12 This includes a capture aptamer fixed to a surface and a reporter aptamer in 
free solution (Figure 1-3A). When the serum is added, the capture aptamer binds its target. The 
rest of the serum is washed away, and the reporter aptamer is added. The reporter aptamer binds 
to the target molecule on a different spot than the detector and emits a detectable signal such as 
radioactivity or fluorescence. The intensity of the signal is correlated to the concentration of the 
target molecule. 
 
Enzyme-linked aptamer assays (ELAA) use enzymes to catalyze a measurable signal.7,12,13 These 
enzymes are often linked onto the reporter aptamer (Figure 1-3B). Horseradish peroxidase (HRP) 
is a commonly used enzyme. When highly-conjugated ring molecules are added into the 
solution, HRP in the presence of hydrogen peroxide will oxidize the molecules, leading to a 
color shift. This color shift can be detected using spectrophotometric methods. When HRP is 
conjugated to an aptamer that binds to a target, HRP activity will be decreased and the color shift 
will be slowed. The color shift rate can be correlated to the concentration of the target molecule 
in the solution. 
  
Using aptamers in conjunction with antibodies is known as enzyme-linked apta-sorbent assays 
(ELASA) (Figure 1-3C).1,9 There are many different configurations for ELASA, including using 





Figure 1-3: Different aptamer-based assay set-ups. A) Two aptamers in the sandwich configuration. The signal 
element on the reporter aptamer could be a fluorescent or radioactive signal. B) Two aptamers in the ELAA 
configuration. The reporter aptamer is conjugated with an enzyme, which catalyzes a color shift in the solution. C) 
An aptamer and an antibody in the ELASA configuration. The system uses a capture antibody and a reporter 
aptamer with an enzyme. 
 
1.3.3 Microfluidics  
Microfluidics is the manipulation of fluids ranging in volume from microliters to picoliters 
allowing a significant reduction in the reagent volume needed in experiments, which decreases 
cost and produced waste.14 The field of microfluidics contains many different techniques and 
technologies, including flow-based,3 droplet-based,15 paper,16 and electrowetting microfluidics.17 
We aim to work within the flow-based microfluidic area. Flow-based microfluidic systems have 
several advantages over other microfluidic techniques, including: 1) generating higher 
throughput, 2) allowing easy experimental automation, and 3) creating higher robustness. 
 
Flow-based microfluidic devices are traditionally made of an elastic, inert polymer, such as 
polydimethylsiloxane (PDMS), and contain a flow and a control layer (Figure 1-4).3 The liquid 
or aqueous solution is passed through the flow layer using external pressure or on-chip pumping 
mechanism. The control layer uses pneumatic valves to stop flow through the flow layer. Many 
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microfluidic devices utilize normally-open valves, where the flow channels are open when no 
pressure is applied to the control channel (Figure 1-5A).18 Normally-closed valves (NCVs) are 
closed when no pressure is applied to the control channels and are typically opened by applying a 
vacuum pressure in the control channel (Figure 1-5B).19. Normally-closed valves allow a 
microfluidic device to be detached from pneumatic controllers and be moved while the liquids 
stay in the same chambers on the chip. This portability is important for assay steps which may 
need to be performed at a range of temperatures. 
 
 
Figure 1-4: The standard layout of a flow-based microfluidic system. Panel A shows the system with no pneumatic 





Figure 1-5: Functions of normally-open and -closed valves. The arrow indicates the direction of flow when the 
channel is open. Panel A shows a normally-open valve before and after a positive pressure is applied to the control 
channel. Panel B shows a normally-closed valve before and after a negative pressure is applied to the control 
channel. 
 
1.3.4 Microfluidic Aptamer Assays 
Aptamer assays have been translated to microfluidic assays. Microfluidic assays use lower 
reagent volumes and tend to be faster than traditional assays.20–22 A study from a group at the 
University of Santa Barbara attempted to develop a platform that performed magnetic bead-
assisted SELEX on a microfluidic scale in order to successfully isolate aptamers after the first 
round of selection.23 The microfluidic device used microfabricated nickel ferromagnetic 
structures. Isolating DNA aptamers that are bound to the light chain of recombinant Botulinum 
neurotoxin type A, they were able to show the potential of the technology with a potent toxin, 
emphasizing its therapeutic and biodefense applications. While no assay was performed on the 
chip, the architecture of the chip theoretically allowed for an assay to be run on it. 
 
A research collaboration between the National Tsing Hua University, Taiwan, and the National 
Cheng Kung University, Taiwan, created a microfluidic aptamer assay to detect glycated 
hemoglobin.12 The dual aptamer assay decreased analysis time from 3.5 hrs to 30 min and 
decreased the reagent volume by 75%. The assay established linear relationships between 
glycated hemoglobin concentration and fluorescence intensity.  
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Several designs incorporate a central pump system within multiple input/output wells (Figure 1-
6). One group utilized a microfluidic chip with a central pump to detect protein thrombin with an 
aptamer sandwich assay.24 Magnets were used to fix magnetic beads to wells during different 
steps. The pump was connected to an external pneumatic device to move the chips in and out. 
This chip had a limit of detection (LOD) for thrombin of 10 ng/mL, which was an improvement 
of the LOD of a well-plate assay of 18 ng/mL. 
 
Another group later improved on this design by adding a central micropump. They designed a 
microfluidic aptamer-assay for the detection of H1N1 virus (Figure 1-6).2 The microfluidic 
device could be run in 30 min and had a comparable limit of detection to a traditional dual-
antibody assay, 0.032 and 0.031hemagglutination units respectively. The device utilized 
normally-closed valves and a central micropump, actuated along with the valves using an 
external pneumatic source with lines leading to the chip, to control the movement of liquid 
throughout the chip. Aptamers were conjugated to magnetic beads, which were fixed in 
chambers for washing steps using a magnet. 
 
Figure 1-6: A schematic of a microfluidic device with a central micropump. Fluids are added or removed in the 
input/output holes and pulled into the central micropump using sequential valve actuation. 
1.4 Back-up Plan 
Our current design relies on normally-closed valves for its portability. If the normally-closed 
valves fail to function properly, normally-open valves could be utilized. The chip could still be 
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used to perform an assay, but the preparation steps would need to be performed off-chip as the 
chip would no longer be portable. 
 
If the micropumps fail to work, the liquid could be moved into the chips using an external 
pressure. However, this would require more set-up; our design intends to have open holes that 
liquids can be pipetted into. With a fluid under pressure, the fluid would need to be placed in a 
device that could apply constant pressure or flow. 
1.5 Significance 
We are developing a microfluidic chip that others will be able to use for the rapid screening of 
various diseases. Our design allows aptamer assays to run with higher efficacy and speed than 
traditional assay systems, all at a lower cost. As aptamers have high binding affinities and 
specificities, they show promise for their biomarker discovery, and for their cancer diagnosis and 
treatment. Microfluidic chips will able to improve aptamer-based assays as they operate with 
higher throughput and sensitivity, using less reagent volume. Combing microfluidics with 
aptamer research will accelerate the rate at which we are able to run assays, potentially allowing 




2. Details of Key Constraints 
2.1 Critiques of Existing Technologies 
While other groups have demonstrated on-chip aptamer-based assays, they still do many 
preparations steps off-chip. In Lou, et al., the group reported a microfluidic chip capable of 
SELEX, but had to perform many analysis steps off-chip, including PCR and binding constant 
determination.23 In the Tseng, et al., the group conjugated the aptamers to the magnetic beads 
off-chip.2 The conjugation steps required multiple reagents and temperatures for maximum 
efficacy, so their choice to perform the steps off-chip made sense. However, when utilizing 
normally-closed valves, microfluidic chips can theoretically be detached from pneumatic 
controls and be moved into an oven or a fridge to hit different temperature regions. In our 
project, we aim to address these portability issues and perform all the steps of the experiment on 
the microfluidic chip.  
 
Many of the chips are also limited in their usage. The chip in Lou, et al., is a linear chip with two 
inlets. The chips design is simple and cannot be easily upscaled within the current design. Also, 
it requires attachment to pneumatic controls to function. The chip presented in Tseng, et al., also 
only has four inputs and outputs, limiting the range of experiments and assays that could be 
performed on a single chip. In our project, we aim to design a system with many inputs/outputs 
that could run multiple assays in parallel. By using multiple micropumps throughout the system, 
we aim to design a modular chip which can move fluid to different chambers.  
 
Lastly, some of the chips require complex microfabrication. The chip in Lou, et al., utilizes 
microfabricated nickel strips. These strips are difficult to print and fabricate in bulk. Using 
simple PDMS structures and an external magnet, we hope to make our chip simple and cheap to 
reproduce for potential diagnostic assays. 
2.2 Analysis of Key Constraints 
For a microfluidic chip to successfully perform aptamer-based assays and compete with existing 
well-plate assays, the assay must be completed in a comparable amount of time and get a 
comparable or better signal. Additionally, multiple assays need to be conducted in parallel. To 
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complete the assay in a comparable amount of time, the micropumps will need to move fluid 
from one chamber to the next in a reasonable amount of time. The microfluidic system should 
have a comparable or better signal due to the higher effective concentration at lower volumes. To 
run multiple assays in parallel, we plan to design a modular system capable of running multiple 
assays on the same chip. Additionally, parallel systems have been utilized in microfluidic 




3. Detailed Design Description 
3.1 First-Generation Chips 
The first-generation chips were designed to test normally-closed valves and flow using normally 
closed-valve and micropumps. We designed two valve array chips (Figure 3-1 and 3-2) and one 
flow test chip (Figure 3-4). With the valve array chips, we aimed to test the actuation pressures 
of the different valves to determine which valve would be most effective with our final design. 
The ideal valve would actuate quickly and not tear at high negative pressures.  
 
With the first-generation chips, we intended to make the flow layer 35-µm tall, the control 
channel 50 µm tall, and the gap between the two layers 15-µm. These values are standard in 
flow-based microfluidics and would not require any difficult fabrication steps. 
 
3.1.1 Actuation Pressure Tests 
For actuation tests, a pin connected to a vacuum source is inserted into the flow layer. Increasing 
amounts of negative pressure are applied to the flow layer until the normally-closed valves open. 
These actuation values are recorded. The tests are repeated across multiple chips to insure 
consistency. In Figure 3-1 and 3-2, we would expect the top rows to require less pressure to open 
than the bottom rows. The surface area of the valve making contact with the glass is smaller for 
the top rows and therefore should require less force to lift off of the surface. Similarly, we would 






Figure 3-1: An array of normally closed valves with consistent control channel valve widths of 700 µm. Left to 
right, the gap between the flow channel increases in 100 µm increments. Top to bottom, the flow channel width 
increases in 100 µm increments, and the width of valves increases to maintain 200 µm on the top and bottom of the 
flow channel. 
 
Figure 3-2: An array of normally closed valves with control channel valve widths increasing in 200 µm increments. 
Left to right, the gap between the flow channel increases in 100 µm increments. Top to bottom, the flow channel 
width increases in 100 µm increments, and the width of valves increases to maintain 200 µm on the top and bottom 
of the flow channel. 
 
3.1.2 Flow Tests 
For flow tests, all three control channels are connected to the vacuum source via pins. For flow, 
we intend to use a stepwise scheme to push fluid through the chip (Figure 3-3). Briefly, the fluid 
is pulled into the central chamber, held there, then pushed through the other side. This pumping 
14 
 
is cyclical and will require multiple sequences to move fluids from one chamber to another. In 
this design, the central control channel is square and a similar size to the NCVs. 
 
Figure 3-3: Normally-closed valve flow schematic. The liquid is moved via the following system: 1) fluid reaches 
the first NCV, 2) negative pressure is applied over the left NCV and the flow pump to suck liquid into the central 
chamber, 3) the left NCV is closed while pressure is maintained over the pump, and 4) pressure is applied over the 
right NCV while the pump is relax to push liquid to the right. The sequence is then repeated until the desired amount 
of fluid reaches the final chamber. 
 
Figure 3-4: A pump test array. Top to bottom, the flow channel height increases in 100 µm increments, and the 
height of valves increases to maintain 200 µm on the top and bottom of the flow channel. The middle control 





3.2 Second-Generation Chips  
From characterization using the first-generation chips, the second-generation chips were 
determined to need longer control lines and use circular valves. All channels were 200 µm wide 
and gap widths for NCVs were 100 µm. The second-generation chips sought to use circular 
micropumps instead of square micropumps. Lastly, the second-generation chips moved towards 
a modular design, where fluids from a variety of inputs and outputs could be moved around the 
chip and combined.  
 
3.2.1 Changing Flow Channel Heights 
Due to results from the first-generation chips, we sought to make our control channels taller. In 
short, we had a problem with the micropumps collapsing to bind to the glass, in which case they 
could no longer be actuated. This severely limited our ability to pump liquids through the chips. 
To counter this issue, we created two flow channel molds with 50-µm and 100-µm tall features, 
respectively. At this height, we would not expect the micropumps to collapse. 
 
3.2.2 Changing Control Channel Heights 
Results from the 50 µm and 100 µm flow channel chips indicated that the 50 µm control layer 
was collapsing on top of the micropump. This limited pumping in a similar way to the last 
micropump collapse. To counter this issue, we created a control channel mold with 100 µm tall 
features. 
3.3 Cartridge-Topper 
In preliminary tests, microfluidic chips ran bubbled off of the glass. Because the PDMS 
connection to the glass substrate is crucial for the microfluidic channels, bubbling disrupts fluid 
flow, allowing fluid to spill out into the surrounding chip. To combat chip bubbling, we designed 
a cartridge topper laser-cut from acrylic (Figure 3-5). This cartridge topper contained the 
pneumatic valves needed to actuate the chips, which no longer needed to be inserted into the 
control channel. The control line holes will likely need to be larger in order to make aligning the 
cartridge head and the microfluidic chip easier. Even pressure will be applied to the cartridge 





Figure 3-5: The cartridge topper schematic. The metal pin in the acrylic cartridge leads to a pneumatic control line, 
which can be used to actuate the valves in the microfluidic chip. The cylinder on top of the acrylic cartridge 




4. Expected Results  
Our method for accomplishing the detection of a virus references the research collaboration 
between the National Tsing Hua University, Taiwan, and the National Cheng Kung University, 
Taiwan.2 Beyond their basic detection method and the utilization of normally-closed valves and a 
central micropump, our project deviated significantly in the scale of our design. 
 
Our microfluidic chip design aims to operate with less reagent volume and more efficiently at 
approximately one third the size of the Taiwanese Research Group’s chip. Additionally, while 
Tseng, et al. displayed successful detection of a single virus, H1N1, our group is aiming to 
design a microfluidic chip that can scale this model up to the detection of various biomarkers on 
a single chip. By making the entire microfluidic chip design smaller, we want to increase the 
number of central microchambers, allowing for a higher throughput design that can challenge the 




5. Materials and Methods 
5.1 Microfluidic Chip Fabrication 
The microfluidic chips were designed in AutoCAD (Autodesk). Fineline Imaging created 
photolithography masks from the AutoCAD designs. Photolithography was used to create molds, 
and soft lithography was used to make PDMS chips from the molds. 
 
5.1.1 Photolithography Process  
For photolithography, SU-8 negative resist was utilized to fabricate the control and the flow 
layer molds. Table 5-1 details specific conditions used at each step to obtain varying mold 
heights. For the flow mold, the silicon wafers were treated with HDMS. SU-8 was placed on the 
wafer, and the flow mold was spin coated. The wafer was soft baked for 90s at 115°. The mold 
was exposed to the photolithography mask and UV light. The layer was developed. Lastly, the 
mold was hard baked starting at 65° and ramping up to 190° over fifteen hours.  
 
For the control mold, SU-8 2015 was spun onto the silicon wafer. The mold was then baked for 
60 s at 65°, 180 s at 95°. The mold was exposed to the photolithography mask and UV light, then 
baked for 60 s at 65°, 180 s at 95°. The mold was then developed with SU-8 and rinsed and 
dried. Lastly, the mold was hard baked starting at 65° and ramping up to 160° over two hours.  
 









35 1800 60 30 1 
50 3000 30 13 5 
100 1500 30 18 8 





5.1.2 Soft Lithography Process 
In soft lithography, the control and flow layer molds are used to form two corresponding layers 
of PDMS. These layers are then bound together to create the final microfluidic chips. For the 
control layer we begin by mixing a 5:1 ratio of PDMS Part A to the PDMS curing agent Part B. 
This combination is then mixed for 2 minutes in a mixer (Thinky). The resulting PDMS is then 
poured over the control mold and degassed in a chamber. After degassing the mold is then baked 
at 80 degrees for 30 minutes.  
 
For the flow layer PDMS is made with a 20:1 ratio of Part A to Part B. PDMS is spin coated over 
the mold at various speeds depending on the height of the mold features (Table 5-2).  The PDMS 
layer is then baked for 30 minutes at 80 degrees.  
 
Table 5-2: Conditions tested to obtain various control and flow channel heights. 
Mold Height [µm] Spin Speed [rpm] Spin Time [s] 
35 2000 30 
50 1400 30 
100 700 30 
200 350 30 
 
 
After baking, the PDMS chips are then peeled from the molds and cut into individual chips. The 
newly cut control layers are hole punched with a 700 µm hole and then placed upon their 
corresponding flow layers and baked in the oven at 80 degrees for 24 hours. After baking, 
inlet/outlet holes are cut for the flow layer with 2 mm holes. The chips are then plated on glass 
and tested.  
5.2 Microfluidic Testing Protocol 
To begin, the vacuum control pins are attached to the corresponding flow inputs. The valves are 
actuated using -20 PSI to ensure actuation when the fluid is later flowed through the system. 
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Then, the reagents are added into the various flow inputs using pipettes or syringes. Lastly, the 
valves are actuated to do flow or mixing automatically using a control box and -20 PSI air 
pressure (Elveflow). In automated tests like flow and mixing, the valves were actuated at 200 ms 
intervals. 
5.3 Flow Rate Calculations 
Flow rate calculations are performed in two ways: an initial flow rate calculation and a longer, 
average flow rate calculation. 
 
For the initial flow rate calculation, the time for the fluid to reach the output from the input while 
the chip is pumping is recorded. The total area of the microfluidic chip traveled by the liquid is 
determined by calculating the area in the AutoCAD designs. This area is multiplied by the flow 
channel height to determine the volume traveled by the liquid. Then the volume is divided by the 
time it took to flow through the chip to determine flow rate, which is converted into the most 
relevant units, either µL/s or nL/s.  
 
For the average flow rate calculation, the volume of the input reservoir is calculated. Input holes 
were punched using a 2 mm hole puncher. The area of the circle is multiplied by the theoretical 
height of the chip, 2 mm. This yields a volume of 6.3 µL. Once pumping begins, the time it takes 
to empty the reservoir is determined. The volume is divided by the time to determine flow rate, 
which is converted to the most relevant units, either µL/s or nL/s.  
5.4 Cartridge Topper 
The cartridge toppers and base were designed in AutoCAD (Autodesk). The topper designs were 
then cut into ⅛ inch acrylic and the base was cut into ⅜ inch acrylic using an Epilog Zing24 
60W laser cutter (Epilog Laser). Four holding-clamps (McMaster-Carr) were fixed to the base 
using bolts, washers, and screws. The height of the toppers was adjusted using washers and bolts 





6.1 Normally-Closed Valve Characterization 
To optimize our NCVs, we tested different NCVs with varying multiple dimensions of the valves 
to determine how these changes impacted the actuation pressure. Specifically, we tested how 
changes in flow channel width, valve gap width, and control channel valve width affected 
actuation pressure (Figure 6-1). 
 
 
Figure 6-1: The three parameters varied in actuation pressure tests. Channel widths varied between 200 µm and 500 
µm, gap widths 200 µm and 500 µm, and valve widths varied between 400 µm and 1000 µm. 
 
Various flow channel widths starting from 200 µm in diameter and increasing by 100 µm up to 
500 µm diameter were used to determine which sizes allowed the valves to actuate with the least 
amount of pressure. Channel width is the width of the channel before and after the normally 
closed valve. As seen in Figure 6-2, it was determined that varying channel width did not 





Figure 6-2: Negative pressure of actuation for NCVs with increasing channel widths. 
 
The next test was conducted to determine the impact of gap width on opening the normally 
closed valves. Gap width is the size of the closed portion of the control channel in the normally 
closed valve. Similar to channel width, gap widths were varied starting from 200 µm in diameter 
and increasing by 100 µm up to a 500 µm diameter. It was determined that as gap width 
increased, the negative pressure required to open the valve also increased. As seen in Figure 6-3, 
this indicates gap width has a positive correlation with opening the NCVs. As gap width 
increases, the normally closed valve has a greater surface area contact with the glass, making the 





Figure 6-3: Negative pressure of actuation for NCVs with increasing gap widths. 
 
The next test was conducted to determine the impact of valve width on opening the normally 
closed valves. Valve width is the size of the vacuum chamber in the normally closed valve. 
Unlike channel and gap width, valve widths were varied starting from 400 µm in diameter and 
increasing in 200 µm steps up to a 1000 µm diameter. It was determined that as valve width 
increased, the negative pressure required to open the valve also decreased. As seen in Figure 6-4, 
this indicates gap width has a negative correlation with opening the NCVs. As valve width 






Figure 6-4: Negative pressure of actuation for NCVs with increasing valve widths.  
 
The final variable changed in optimization of the normally closed valves was testing different 
geometric shapes for the valves. In this experiment we test rectangular valves in the first-
generation chips versus circular valves used in the second-generation chips. It was determined 
that square valves require a greater amount of negative pressure to actuate them. Across 25 trials, 
square valves opened at an average of -10.75 PSI, whereas the circular valves opened at an 
average of -4.36 PSI. Circular valves required less than half the amount of pressure to actuate 
and open the valves. These tests indicate that the optimum design for the NCVs are circular 
valves with a gap width of 200 µm.  
6.2 Flow Demonstration with Oil 
Flow was demonstrated on the second-generation chips with varying flow channel and control 
channel heights. Flow could not be generated on the chips with 50 µm tall flow and 50 µm tall 
control channels. The micropumps were collapsed and were insufficient to move oil beyond its 
natural flow due to its low surface energy. Flow was demonstrated on chips with 100 µm tall 
flow and 50 µm and 100 µm tall control channels. 
 
6.2.1 Oil Flow on Chips with 100 µm Tall Flow Channels and 50 µm Tall Control Channels 
Basic flow was demonstrated on the three-input chips with 100 µm tall flow channels from the 
second generation. First, 6.3 µL of dyed oil was placed in one input, and the sequential pumping 
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sequence was used to pull the dye into the central chamber with the valves and micropump 
actuating every 200 ms (Figure 6-5). The dye was then pumped from the central chamber into 
another input valve. Moving the liquid from one input to the other took ~5 minutes at a rate of 2 
nL/s. 
 
Figure 6-5: Sequential flow through a three-input 100 µm tall flow and 50 µm tall control channels chip. A) The 
fluid is inserted into an input and naturally flows to the first NCV, B) using the central micropump, liquid is pulled 
into the central micropump and pushed towards the upper-left input, and C) continuing to use the micropump, fluid 
is moved to the upper-right input. 
 
While flow was demonstrated, it was quite slow. The flow seems to be slow due to the collapse 
of the micropump (Figure 6-6). The control layer seems to be collapsing into the membrane. 
These fuses likely occur due to sagging during fabrication, resulting in the two layers being 
baked together. When actuated, these collapsed valves will only actuate around the edges (Figure 






Figure 6-6: Actuation of the 100 µm tall flow channel and 50 µm tall control channel micropumps. The collapse is 
shown in the center of the pump by the circle. A) The pump in the resting state with no pressure applied, and B) the 
pump with pressure applied. The thin darkened ring pointed at by the arrow is the area of the valve we see deflect. 
 
6.2.2 Oil Flow on Chips with 100 µm Tall Flow Channels and 100 µm Tall Control Channels 
In initial tests with the 100 µm tall flow and 100 µm tall control channels, the standard -20 PSI 
was not sufficient to consistently actuate the valves or the micropump. The vacuum pressure was 
adjusted up to -35 PSI, and the valves consistently actuated.  
 
Flow from the input to the output through the micropump using oil was successful (Figure 6-7). 
Again, 6.3 µL of dyed oil was placed in one input. The valves were actuated every 200 ms. The 
flow rate vastly improved. It took 4 seconds to move the oil from the input to the output at a flow 
rate of 150 nL/s, and 1 minute to empty the input channel at a flow rate of 1.05 µL/s. The 
discrepancy in flow rate is probably due to more fluid being drawn into the pump over time. The 
micropump showed no indication of collapse. The circle shown in the center of the micropump 
was the center membrane touching the top of the control channel when actuated (Figure 6-7C). 
This provided significantly more negative pressure into the micropump and is likely the cause of 





Figure 6-7: Flow through the 100 µm tall flow and 100 µm tall control channel chip with oil. A) The fluid is 
inserted into an input, B) using the central micropump, liquid is pulled into the central micropump and pushed 
towards the lower-right output, and C) continuing to use the micropump, fluid is moved to the upper-right input. 
6.3 Mixing Demonstration Using Oil 
After flow was demonstrated, differently colored oils were inserted into another input and pulled 
into the micropump to be mixed.  
 
6.3.1 Mixing Oils on Chips with 100 µm Tall Flow Channels and 50 µm Tall Control Channels 
To show mixing, a blue oil was introduced into the third input of a three-input chip (Figure 6-8). 
The oil was brought into the central micropump using a sequential flow with 200 ms intervals 
between actuations. The dyes diffused minimally into each other where they met but did not truly 
mix together. Roughly equal amounts of the liquids did fill the chamber, which is promising for 





Figure 6-8: Sequential mixing in a three-input chip. A) The fluid is inserted into the third input and naturally flows 
to the first NCV, B) using the central micropump, liquid is pulled into the central micropump, and C) the pump 
continues running until roughly equal amounts of the liquids are present. 
 
6.3.2 Mixing Oils on Chips with 100 µm Tall Flow Channels and 100 µm Tall Control Channels 
Similar to flow, mixing was vastly improved on the chips with 100 µm tall flow and 100 µm tall 
control channels. Due to the greater pumping efficiency, it was much more difficult to fill up the 
central micropump without having backflow down the input lane. The micropump was filled as 
much as possible to start (Figure 6-9A). Next, blue oil was pulled in from the upper right input 
(Figure 6-9B). The two colored mixed until the blue dye ran out (Figure 6-9C). The two oils 
successfully mixed together, despite the difficulties completely filling up the micropump 
completely. The yellow dye running up into the input at the start was due to a previous 





Figure 6-9: Sequential mixing in a 100 µm tall flow and 100 µm tall control channel chip with oil. A) The fluid is 
inserted into the third input, B) using the central micropump, liquid is pulled into the central micropump, and C) the 
pump continues to mix the liquids until the two colors are mixed.  
6.4 Modular Chip Demonstration Using Oil 
Once flow and mixing had been demonstrated using our micropumps, we aimed to show 
modular flow using our modular chip design. To run an aptamer-based assay on our microfluidic 
device, fluid will need to be moved from one section of the chip to another. For the 
demonstration, we moved fluid from two inputs across two micropumps (Figure 6-10). Then, we 
pumped one of the liquids into the other to demonstration mixing. During the mixing, the liquids 
did not truly mix, again; however, equal amounts of both liquids seemed to be present in the final 
chamber. Moving the fluids across two micropumps took ~15 minutes for a flow rate of 20 nL/s 
and pumping one fluid into the other took ~5 minutes. The difference in the flow rate between 
the 100 µm tall flow and 50 µm tall control channel chip and this modular chip is likely due to 





Figure 6-10: Sequential mixing in a three-input chip. A) The fluid is inserted into the third input and naturally flows 
to the first NCV, B) using the central micropump, liquid is pulled into the central micropump, and C) the pump 
continues running until roughly equal amounts of the liquids are present. 
6.5 Mixing and Flow Using Water-Based Solutions 
After flow and mixing were demonstrated using oil, we sought to use water-based solutions on 
the chips. In attempts with chips with 100 µm tall flow and 50 µm tall control channels, the 
negative pressure from the collapsed micropumps was insufficient to overcome the repelling 
interaction between PDMS and water. Using 100 µm tall flow and 100 µm tall control channels 
and the higher vacuum pressure, we were able to demonstrate water flow and mixing. 
 
6.5.1 Water Flow on Chips with 100 µm Tall Flow Channels and 100 µm Tall Control Channels 
The micropump pulled water through the chip using actuation 200 ms increments (Figure 6-11). 
Water was moved from the bottom right input to the central micropump to the upper left output. 
An oil-based dye was used, and it did not initially travel with the water. The water movement 
can be seen in the bubble and reflection in Figure 6-11B and in the reflection in Figure 6-11C. 
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Similar to flow with oil, the water took 5 seconds to reach the upper left output at a flow rate of 
1.32 µL/s and ~20 seconds to empty the input well at a flow rate of 3.14 µL/s. The discrepancy 
in flow rates again is likely due to the pump fully filling up. 
 
 
Figure 6-11: Flow through the 100 µm tall flow channel and 100 µm tall control channel micropump using water. 
A) Water with a yellow oil-based dye was inserted into the input, B) the water was pulled into the central 
micropump, and C) the water was pumped to the upper left output.  
 
6.5.2 Mixing Water-Based Solutions on Chips with 100 µm Tall Flow Channels and 100 µm Tall 
Control Channels 
We demonstrated mixing using water-based solutions (Figure 6-12). Given the oil-based dyes, 
the mixing was difficult to visualize. The change of volume in the chamber indicated by the 





Figure 6-12: Sequential mixing in a 100 µm tall flow and 100 µm tall control channel chip with water. A) A blue 
oil-based dye and water was inserted, B) the blue water was pulled into the micropump, C) the bubbles dissipated 
indicating the blue-dye is brought into the chamber. 
6.6 Actuation Using the Cartridge-Topper 
The valve and micropump actuation were demonstrated using the cartridge topper (data not 
shown). The cartridge-topper was set-up and visualized under the microscope (Figure 6-13). To 
fabricate chips to be compatible with the cartridge topper, 2.5 mm holes are cut for the control 
lanes. This makes them easier to align with the holes. Ideally, the chip would be larger than all 
the holes, so fluids could be inserted into the holes of the cartridge. Figure 6-13B highlights how 
the large control and input holes can obscure the features underneath. The acrylic can also be 





Figure 6-13: The cartridge topper with a microfluidic chip. A) the system set-up under the microscope, and B) a 







7. Discussion  
7.1 Normally-Closed Valve Characterization  
Normally-closed valves are essential to our design because they allow the microfluidic chip to be 
transported to different temperature areas. Since we aim to do all the assay steps on chip, we will 
need to incubate different reactions at different temperatures. Normally-closed valves ensure the 
fluids stay in their chamber while the chip is disconnected from pneumatic controls. 
 
In the characterization of our normally-closed valves, we established two relationships between 
the dimensions of the valve and the actuation pressure needed to open the valve. First, we found 
increases in channel width within 200-500 µm did not lead to increases in the pressure required 
for valve actuation. As channel width increased in our designs, the width of the valve also 
increased. Therefore, the surface area of the valve relative to the control lane stayed constant. 
 
Second, we found that increasing the gap width between the flow layers lead to a linear increase 
in actuation pressure from 200-500 µm. As gap width increases, the relative surface area of the 
valve to the control lane increased. An increase in the surface area of the valve relative to the 
control lane is expected to increase actuation pressure, so our results agreed with results we saw 
in literature. 
 
Third, we found that increasing the width of the valve lead to a linear decrease in actuation 
pressure from 200 µm to 1000 µm. Increasing valve width provides a greater area in the control 
channel to apply vacuum pressure, essentially making the valves easier to open due to a greater 
net force. 
 
Lastly, we compared rectangular and circular valves. At the same gap width, circular valves 
actuated at approximately half the negative pressure of rectangular valves. Rectangular valves 
suffered from bursting at higher pressures, likely due to corners ripping. Circular valves mitigate 
this issue. Across roughly 25 tests with circular valves, we only observed a valve bursting once. 
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7.2 Characterization of the Microfluidic Platform 
For our microfluidic platform to successfully run aptamer-based assays, it needs to demonstrate 
flow, mixing, and modular movement across the chip. 
 
To be capable of running an aptamer-based assay, our chip needs to move liquids from one 
chamber to another and mix two liquids together. We initially tested flow using oils because the 
low surface energy of oils means they will readily move through PDMS. Using oil, we 
successfully demonstrated flow and mixing in microfluidic chips with 100 µm tall flow and 50 
µm tall control channels and 100 µm tall flow and 100 µm tall control channels. Moving from 50 
to 100 µm tall control channels, we increased our vacuum and saw a tremendous increased in the 
negative pressure applied by our micropump. Flow from one input to another was reduced from 
~5 minutes to ~5 seconds with oils. Initially, the chip achieved a flow rate of 150 nL/s. It took 1 
minute to empty the input reservoir at a flow rate of 1.05 µL/s. The discrepancy in flow rate is 
probably due to the pump not completely filling during the initial calculation. Another source of 
error could be the estimated 2 mm height of the chip. We occasionally saw chips that were 
different heights on the molds due to a sloped surface during baking.  Using the 100 µm tall flow 
and 50 µm tall control chips, we were able to bring equal volumes of dye into a micropump but 
were unable to mix them. Using the 100 µm tall flow and 100 µm tall control chips, we were 
able to successfully mix the oils in the micropump. Due to the greater negative pressure 
generated by the micropump, we had difficulty moving equal volumes into the chip.   
 
After the oil-based flow and mixing, we moved to water-based solutions. Aptamer-based assays 
are water-based, so our chips need to be compatible with them. Additionally, we sought to avoid 
treating the PDMS because it could add reactive chemical groups and sought to not use 
detergents to lower the surface energy of water because they could potentially interfere with the 
reagents in the aptamer-based assay. Attempts to use water on the 100 µm tall flow 50 µm tall 
control chips proved unsuccessful. Due to the collapse in the micropump, the micropump could 
not provide adequate pressure to overcome the hydrophobic/hydrophilic interactions between the 
PDMS and water. Using the 100 µm tall flow and 100 µm tall control chips, we were able to 
show flow from one input to an output in 5 seconds at a flow rate of 1.32 µL/s and took ~20 
seconds at a flow rate of 3.14 µL/s to empty the reservoir. This water flow rate is notably higher 
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than the oil flow rate. The oil tests were performed on a micropump with a radius of 1250 µm 
and the water tests were performed on a micropump with a radius of 750 µm. Further work needs 
to be done to determine the flow rate differences between these two pumps (discussed in section 
7.4). 
 
Lastly, we demonstrated movement of liquids across our 3x2 micropump chip. The modular chip 
provides a powerful platform for running assays. Single or multiple assays can be run on the chip 
by segmenting the different reactions in different micropumps. The modular design could easily 
be upscaled to include more inputs/outputs and micropumps. The modular design has the 
potential to provide high throughput analysis for diseases or biochemical assays. 
7.3 Cartridge-Topper 
The cartridge-topper provides a means to rapidly connect a complex microfluidic chip to 
pneumatic controls. Instead of inserting multiple vacuum pins, the cartridge is simply aligned 
over the chip and pressure is applied to the cartridge to hold it in place and prevent liquids from 
flowing out of the reservoirs on the chips. If multiple assays are being sequentially run, the 
cartridge-topper provides a rapid means to hook-up a new chip. The cartridge-topper also 
improves our ability to make our microfluidic chip portable, as it eliminates the need to 
disconnect and reconnect pneumatic lines when moving the chip and prevents the chip from 
peeling from the glass during disconnections.. 
 
Using the cartridge-topper, we successfully demonstrated actuation of valves and the 
micropump. Given this successful actuation, the cartridge topper could be used to perform future 
tests on our microfluidic devices. 
7.4 Future Work 
Several experiments still need to be done to characterize and improve our chips. For all of our 
flow experiments, we used 200 ms valve actuation steps. Further work could be done to 
characterize flow speeds at other frequencies. Additionally, we saw an increase in flow speed 
and micropump efficiency when we switched to a vacuum capable of providing a greater 
negative pressure. Further work could be done to test a range of vacuum pressures between -20 
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to -50 PSI to determine the optimal vacuum pressure. As noted in our results, at the increased 
vacuum pressure, we had difficulty filling up a micropump, which would be important for an 
aptamer-based assay. Likely, the pressure needs to be decreased for these steps. Lastly, we tested 
micropumps of different sizes, including 750, 1000, and 1250 µm radius, and further work could 
be done to determine the differences in flow rate between these micropumps. 
 
Lastly, we need to perform a proof-of-concept aptamer-based assay on our microfluidic device. 
We propose performing an assay to target nucleolin, a protein involved in the synthesis and 
maturation of ribosomes. An aptamer has been previously been isolated for nucleolin, as 
described in Guo, et al..26 Aptamers would be ordered with the known sequence and with a 
amide group on one tail. These aptamers would be put in a compatible buffer and inputted into 
the 3x2 micropump chip. Carboxylic nanoparticles, likely 500 nm - 1 µm in diameter, would be 
combined with EDC, a carboiimide crosslinker (ThermoFisher). The nanoparticles and aptamers 
would be brought into a single chamber and incubated for 2 hours at 2° C. The conjugated 
aptamer-nanoparticles would then be held in place using a magnet and wash to remove any 
excess aptamers. Next, nucleolin would be introduced into the system and be allowed to bind to 
the aptamers. After a sufficient incubation, the excess nucleolin would be rinsed away. Next, 
another aptamer or a nucleolin antibody would be added. Either would likely be conjugated to 
horseradish peroxidase to catalyze a color-based reaction, which would indicate the amount of 





8. Engineering Standards and Realistic Constraints 
8.1 Ethical 
Our microfluidic device has the potential to positively impact society by providing a fast, simple 
means to run diagnostic assays. Patients receiving accurate medical information lets them make 
informed decisions about their medical treatment, leading to a net-positive in society. According 
to utilitarian ethics, maximizing societal utility and individual well-being is ethically sound. We 
believe our chip has the potentially to positively impact society though its diagnostic potential. 
8.2 Science, Technology, and Society and Civic Engagement 
The microfluidic devices presented here will positively impact the science community by 
providing an easy-to-use assay system. This system can remove some tedious steps of traditional 
microplate assays. Once assays are developed on this system, we foresee that it could be easily 
adapted into medical environments for the screening of a wide variety of diseases.  
 
When assays are developed on the chip, they will need to be evaluated by the FDA for their 
efficacy before they are sold or distributed to medical professionals. The assays would need to 
effectively determine if the target analytes were present, and medical professionals would need 
to understand what the presence of the analytes indicated about the patients’ health. 
8.3 Economic 
Our microfluidic device is cheap to manufacture and aptamer-based assays prevent a cheaper 
alternative to traditional antibody-based assays. Our device is simple and make of PDMS, which 
is a cheaper polymer. The cartridge topper is made of acrylic, another readily available and 
cheap material, and several inexpensive mechanical parts. Aptamer-based assays are cheaper 
than antibody-based assays because aptamers are much cheaper to produce due to advances in 




8.4 Health and Safety 
Microfluidic chips present minimal health risks and have the potential to provide diagnostic 
benefits to patients. Operating the chips is straightforward and safe. Diagnostic platforms allow 
screening of a variety of diseases and conditions to provide an overall benefit to public health. 
Early disease detection can lead to higher survival rates and give patients more options when 
treating diseases. Overall, we feel the impact of our microfluidic devices will be positive.  
8.5 Manufacturability and Usability 
The microfluidic chips presented here are fairly easy to fabricate. The molds made from 
photolithography can be reused to make many chips as long as they are handled with care. 
PDMS is a simple polymer to mix, pour, and work with. The most technically challenging part of 
the fabrication is punching the control channel holes and aligning the two layers together. Using 
manufacturing robots, this process could be easily automated to produce large amounts of our 
chips.  
 
The cartridge topper makes the chips easy to use. The chips merely have to be aligned under the 
topper, eliminating the tedious steps of connecting multiple pneumatic control lines. Once 
aligned and pressure is applied on the cartridge topper, fluids can be pipetted into the holes on 
the cartridge topper. With the modular aspects of the device, a wide variety of assays could be 
run with our microfluidic design. Future designs could incorporate more inputs/outputs to allow 
for even greater usability and control. 
8.6 Sustainability and Environmental Impact 
The microfluidic chips in this project have the potential to increase the sustainability of 
diagnostic assays by utilizing less resources and having the potential to be reusable. The assays 
are smaller than well-plates traditionally used for diagnostics, utilizing less resources per test. 
PDMS is an elastic material and could theoretically be used for multiple runs of a single test, 
eliminating the need to use a new chip every time. If an efficient cleaning method is developed, 




The chips lessen the environmental impact of traditional assays by using less reagent volume 
than traditional diagnostic assays. Working on the microscale requires less volume, meaning less 
buffers, aptamers, signaling elements, etc. need to be used. PDMS is also an inert polymer and 
does not present any toxic effects. Utilizing “green chemistry” in the assay could also further 
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